Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) 2021 net profit increased by 29% year-on-year, and it is proposed to pay 5.6 yuan for 10

Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) released the annual report. In 2021, the company achieved an operating revenue of 39.005 billion yuan, a year-on-year increase of 28.70%; The net profit attributable to shareholders of listed companies was 4.735 billion yuan, a year-on-year increase of 29.28%. The basic earnings per share is 1.85 yuan. The company plans to distribute a cash dividend of 5.60 yuan (before tax) for every 10 shares.